breast neoplasms/albumin

FIELD OF THE INVENTION This invention relates generally to the identification of new disease-specific markers, in particular the identification of markers specific for a given cancer or cancer stage, and the use of such markers to determine a diagnosis, prognosis or therapeutic treatment for a

TECHNICAL FIELD The present invention relates to methods and kits for the treatment of breast cancer based on hormone receptor status of the progesterone receptor and the estrogen receptor comprising the administration of a taxaric alone, in combination with at least one other and other therapeutic

TECHNICAL FIELD The present invention relates to methods and kits for the treatment of breast cancer based on hormone receptor status of the progesterone receptor and the estrogen receptor comprising the administration of a taxane alone, in combination with at least one other and other therapeutic

TECHNICAL FIELD The present invention relates to methods and kits for the treatment of breast cancer based on hormone receptor status of the progesterone receptor and the estrogen receptor comprising the administration of a taxane alone, in combination with at least one other and other therapeutic

COPYRIGHT NOTICE/PERMISSION A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure as it appears in the Patent and

COPYRIGHT NOTICE/PERMISSION A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure as it appears in the Patent and

FIELD The present invention, in some embodiments thereof, relates to methods and devices for determining a disease state in a patient. In some embodiments, human serum albumin may be analyzed for associated molecules, wherein the associated molecules are related to a disease such as

FIELD OF THE INVENTION This invention relates to compositions comprising taxanes or taxoids and proteins, such as albumin or transferrin, useful for the treatment of cancers. BACKGROUND OF THE INVENTION Taxanes are a family of compounds that includes paclitaxel, a cytotoxic natural product, and

BACKGROUND OF THE INVENTION Technical Field The present invention relates to a targeted sustained release PLA-PEG-PLA nanoparticle loaded with a breast cancer therapeutic agent. Description of the Related Art The "background" description provided herein is for the purpose of generally presenting the

BACKGROUND OF THE INVENTION Technical Field The present invention relates to a targeted sustained release PLA-PEG-PLA nanoparticle loaded with a breast cancer therapeutic agent. Description of the Related Art The "background" description provided herein is for the purpose of generally presenting the